MannKind | MNKD - Dochód Netto





Dochód Netto Zmiana Data
Adma Biologics USD 45.33M 4.05M 2026-03
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Insmed USD -13.24M 150.32M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
MacroGenics USD -36.77M 22.62M 2026-03
MannKind USD -16.62M 671K 2026-03
Merck USD -1.34B 2.9B 2026-06
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Novavax USD 17.53M 219.91M 2025-12
Novo Nordisk DKK 3.26B 45.29B 2026-06
Pfizer USD -248M 2.94B 2026-06
Sanofi EUR 343M 1.27B 2026-06
Xencor USD -21.73M 107.19M 2026-06